Insmed (NASDAQ:INSM) Price Target Raised to $237.00
Insmed (NASDAQ:INSM – Free Report) had its target price upped by Barclays from $231.00 to $237.00 in a research note released on Wednesday,Benzinga reports. Barclays currently has an overweight rating on the biopharmaceutical company’s stock. Several other brokerages have also commented on INSM. Citigroup restated an “outperform” rating on shares of Insmed in a research […]
LGN (NASDAQ:LGN) Price Target Raised to $63.00
LGN (NASDAQ:LGN – Free Report) had its price objective hoisted by BMO Capital Markets from $46.00 to $63.00 in a report released on Monday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock. LGN has been the topic of a number of other reports. Stifel Nicolaus lifted their price objective on shares […]
Popular (NASDAQ:BPOP) Price Target Raised to $163.00
Popular (NASDAQ:BPOP – Free Report) had its target price hoisted by Wells Fargo & Company from $135.00 to $163.00 in a report released on Monday,Benzinga reports. The firm currently has an overweight rating on the bank’s stock. A number of other research analysts have also recently commented on the stock. Credit Suisse Group set a […]
Biogen (NASDAQ:BIIB) Price Target Raised to $275.00 at Oppenheimer
Biogen (NASDAQ:BIIB – Get Free Report) had its target price increased by equities researchers at Oppenheimer from $250.00 to $275.00 in a research report issued to clients and investors on Wednesday,MarketScreener reports. The firm currently has an “outperform” rating on the biotechnology company’s stock. Oppenheimer’s price target would suggest a potential upside of 49.80% from […]
Fastenal (NASDAQ:FAST) Price Target Raised to $46.00 at Wolfe Research
Fastenal (NASDAQ:FAST – Get Free Report) had its target price lifted by Wolfe Research from $43.00 to $46.00 in a report released on Tuesday,MarketScreener reports. The brokerage currently has an “underperform” rating on the stock. Wolfe Research’s price target points to a potential downside of 0.55% from the company’s current price. A number of other […]
Viper Energy (NASDAQ:VNOM) Price Target Raised to $57.00 at Citigroup
Viper Energy (NASDAQ:VNOM – Get Free Report) had its price target lifted by stock analysts at Citigroup from $52.00 to $57.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the oil and gas producer’s stock. Citigroup’s price target would indicate a potential upside […]
APA (NASDAQ:APA) Price Target Raised to $45.00 at Stephens
APA (NASDAQ:APA – Get Free Report) had its price target increased by Stephens from $24.00 to $45.00 in a research note issued to investors on Tuesday,MarketScreener reports. The brokerage currently has an “equal weight” rating on the stock. Stephens’ price target would suggest a potential upside of 7.60% from the company’s current price. Other equities […]
Wedbush Raises Vor Biopharma (NASDAQ:VOR) Price Target to $15.00
Vor Biopharma (NASDAQ:VOR – Get Free Report) had its price target hoisted by equities research analysts at Wedbush from $9.00 to $15.00 in a note issued to investors on Tuesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Wedbush’s target price would indicate a potential downside of 12.71% from the stock’s previous […]
Satellos Bioscience (NASDAQ:MSLE) Price Target Raised to $11.00
Satellos Bioscience (NASDAQ:MSLE – Get Free Report) had its price objective raised by equities researchers at HC Wainwright from $1.20 to $11.00 in a research note issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price target would suggest a potential upside of 77.71% from the stock’s current […]
Host Hotels & Resorts (NASDAQ:HST) Price Target Raised to $23.00
Host Hotels & Resorts (NASDAQ:HST – Free Report) had its price objective hoisted by Truist Financial from $21.00 to $23.00 in a research note released on Thursday morning,Benzinga reports. Truist Financial currently has a buy rating on the stock. HST has been the subject of a number of other research reports. Cantor Fitzgerald increased their […]
Ondas (NASDAQ:ONDS) Price Target Raised to $18.00
Ondas (NASDAQ:ONDS – Free Report) had its target price hoisted by Northland Securities from $16.00 to $18.00 in a research note published on Thursday,Benzinga reports. They currently have an outperform rating on the stock. A number of other equities analysts also recently issued reports on ONDS. Weiss Ratings restated a “sell (e+)” rating on shares […]
APA (NASDAQ:APA) Price Target Raised to $45.00
APA (NASDAQ:APA – Free Report) had its price objective boosted by Raymond James Financial from $31.00 to $45.00 in a research report sent to investors on Wednesday morning,MarketScreener reports. The brokerage currently has an outperform rating on the stock. A number of other research firms have also recently commented on APA. Bank of America raised […]
Insmed (NASDAQ:INSM) Price Target Raised to $213.00
Insmed (NASDAQ:INSM – Free Report) had its price objective increased by Bank of America from $211.00 to $213.00 in a research note issued to investors on Tuesday morning,Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. Several other equities analysts also recently weighed in on INSM. Barclays assumed coverage on […]
Abivax (NASDAQ:ABVX) Price Target Raised to $148.00
Abivax (NASDAQ:ABVX – Free Report) had its price target upped by Barclays from $142.00 to $148.00 in a research note published on Tuesday morning,Benzinga reports. They currently have an overweight rating on the stock. A number of other brokerages have also issued reports on ABVX. Guggenheim reiterated a “buy” rating and set a $175.00 target […]
APA (NASDAQ:APA) Price Target Raised to $40.00
APA (NASDAQ:APA – Free Report) had its target price lifted by Evercore from $25.00 to $40.00 in a research note issued to investors on Tuesday morning,MarketScreener reports. The firm currently has a neutral rating on the stock. Other equities analysts also recently issued research reports about the company. UBS Group boosted their target price on […]
MetroCity Bankshares (NASDAQ:MCBS) Price Target Raised to $32.00
MetroCity Bankshares (NASDAQ:MCBS – Free Report) had its target price hoisted by Keefe, Bruyette & Woods from $31.00 to $32.00 in a research report report published on Monday morning,Benzinga reports. They currently have a market perform rating on the stock. A number of other brokerages have also recently commented on MCBS. Weiss Ratings upgraded MetroCity […]
Zura Bio (NASDAQ:ZURA) Price Target Raised to $11.00
Zura Bio (NASDAQ:ZURA – Free Report) had its price target increased by Chardan Capital from $10.00 to $11.00 in a research note issued to investors on Monday,Benzinga reports. They currently have a buy rating on the stock. A number of other equities research analysts have also issued reports on the company. Leerink Partners upgraded Zura […]
Amazon.com (NASDAQ:AMZN) Price Target Raised to $315.00 at Tigress Financial
Amazon.com (NASDAQ:AMZN) had its target price increased by equities research analysts at Tigress Financial from $305.00 to $315.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the e-commerce giant’s stock. Tigress Financial’s target price would indicate a potential upside of 48.82% from the […]
Leonardo DRS (NASDAQ:DRS) Price Target Raised to $55.00
Leonardo DRS (NASDAQ:DRS – Get Free Report) had its price target raised by analysts at Bank of America from $50.00 to $55.00 in a report issued on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Bank of America‘s target price indicates a potential upside of 21.55% from the stock’s current price. […]
Intuitive Machines (NASDAQ:LUNR) Price Target Raised to $22.00
Intuitive Machines (NASDAQ:LUNR – Get Free Report) had its price objective lifted by equities research analysts at Stifel Nicolaus from $20.00 to $22.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. Stifel Nicolaus’ price target suggests a potential upside of 11.64% from the company’s previous […]
Repligen (NASDAQ:RGEN) Price Target Raised to $208.00
Repligen (NASDAQ:RGEN – Get Free Report) had its price objective boosted by investment analysts at HC Wainwright from $180.00 to $208.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. HC Wainwright’s price target indicates a potential upside of 82.65% […]
Heartflow (NASDAQ:HTFL) Price Target Raised to $43.00
Heartflow (NASDAQ:HTFL – Free Report) had its target price increased by Canaccord Genuity Group from $40.00 to $43.00 in a report published on Thursday morning,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other equities research analysts have also commented on HTFL. Wells Fargo & Company reduced their price target […]
Arvinas (NASDAQ:ARVN) Price Target Raised to $16.00
Arvinas (NASDAQ:ARVN – Free Report) had its price objective raised by BTIG Research from $14.00 to $16.00 in a research note released on Thursday,Benzinga reports. They currently have a buy rating on the stock. A number of other research analysts also recently commented on ARVN. Barclays boosted their price objective on shares of Arvinas from […]
Five Below (NASDAQ:FIVE) Price Target Raised to $261.00
Five Below (NASDAQ:FIVE – Free Report) had its price objective hoisted by Truist Financial from $236.00 to $261.00 in a research note published on Thursday morning,Benzinga reports. The brokerage currently has a buy rating on the specialty retailer’s stock. Several other brokerages have also recently issued reports on FIVE. Morgan Stanley boosted their price objective […]
Red Cat (NASDAQ:RCAT) Price Target Raised to $20.00
Red Cat (NASDAQ:RCAT – Free Report) had its price objective lifted by Needham & Company LLC from $16.00 to $20.00 in a report issued on Thursday morning,Benzinga reports. The firm currently has a buy rating on the stock. RCAT has been the subject of a number of other reports. Weiss Ratings reiterated a “sell (d-)” […]
last updated on 5 Apr 01:09